Cullinan Therapeutics (CGEM) Change in Account Payables: 2020-2024
Historic Change in Account Payables for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to -$812,000.
- Cullinan Therapeutics' Change in Account Payables rose 34.67% to $1.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$167,000, marking a year-over-year increase of 67.19%. This contributed to the annual value of -$812,000 for FY2024, which is 386.23% down from last year.
- As of FY2024, Cullinan Therapeutics' Change in Account Payables stood at -$812,000, which was down 386.23% from -$167,000 recorded in FY2023.
- In the past 5 years, Cullinan Therapeutics' Change in Account Payables registered a high of $5.6 million during FY2020, and its lowest value of -$4.8 million during FY2021.
- Its 3-year average for Change in Account Payables is -$496,000, with a median of -$509,000 in 2022.
- As far as peak fluctuations go, Cullinan Therapeutics' Change in Account Payables soared by 89.47% in 2022, and later crashed by 386.23% in 2024.
- Over the past 5 years, Cullinan Therapeutics' Change in Account Payables (Yearly) stood at $5.6 million in 2020, then tumbled by 186.63% to -$4.8 million in 2021, then soared by 89.47% to -$509,000 in 2022, then spiked by 67.19% to -$167,000 in 2023, then plummeted by 386.23% to -$812,000 in 2024.